{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T06:50:07Z","timestamp":1764831007161,"version":"3.46.0"},"reference-count":37,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T00:00:00Z","timestamp":1758153600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Grants-in-Aid for Scientific Research on Priority Areas of Cancer"},{"name":"Scientific Research on Priority Areas of Cancer Epidemiology from MEXT","award":["20390156","26293138","JP 16H06277","21K08801","25K11229"],"award-info":[{"award-number":["20390156","26293138","JP 16H06277","21K08801","25K11229"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Insulin-like growth factors (IGFs) are potent mitogens and IGF-binding protein 3 (IGFBP3) can regulate IGF activity. To elucidate relationships between IGF-related molecules and risk of pancreatic cancer, we analyzed associations between serum levels of IGF1 and IGFBP3 and incidence of pancreatic cancer in a prospective, nested, case-control study within the Japan Collaborative Cohort study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A baseline survey was conducted from 1988 to 1990, during which period blood samples were obtained from 39\u2009242 subjects. Subjects who had been diagnosed with pancreatic cancer by 1997 were regarded as cases. Conditional logistic regression was used to estimate odds ratios (ORs) for the incidence of pancreatic cancer in relation to serum levels of IGF1 and IGFBP3.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>This analysis included 72 cases and 216 controls. Free IGFBP3 (estimated as IGFBP3\u2013IGF1) was associated with the risk of pancreatic cancer (P for trends\u00a0=\u00a00.011), with the third tertile showing the highest risk (OR\u00a0=\u00a03.42, 95%CI\u00a0=\u00a01.31\u20138.91). None of total IGF1, free IGF1 (estimated as IGF1\/IGFBP3), or total IGFBP3 were associated with risk of pancreatic cancer. This result remained unchanged in subanalyses of male, female, and older subjects (P for trends\u00a0=\u00a00.017, 0.030, and 0.007, respectively). When limiting analysis to participants followed for over 2\u00a0years, free IGFBP3 was associated with risk of pancreatic cancer (P for trends\u00a0=\u00a00.025).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our findings suggest that free IGFBP3 is associated with the risk of pancreatic cancer.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/jjco\/hyaf146","type":"journal-article","created":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T11:48:09Z","timestamp":1756813689000},"page":"1365-1371","source":"Crossref","is-referenced-by-count":0,"title":["Insulin-like growth factor-binding protein 3 and incidence of pancreatic cancer in a nested case-control study"],"prefix":"10.1093","volume":"55","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2530-1745","authenticated-orcid":false,"given":"Yasushi","family":"Adachi","sequence":"first","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Sapporo Medical University , S-1, W-16, Chuo-ku, Sapporo , Hokkaido 060-8543,","place":["Japan"]},{"name":"Division of Gastroenterology, Department of Internal Medicine, Sapporo Shirakaba-dai Hospital , 7-26, 18 Choume, Tsukisamu Higashi 2 Jo, Toyohira-ku, Sapporo , Hokkaido 062-0052,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanori","family":"Nojima","sequence":"additional","affiliation":[{"name":"The Institute of Medical Science Hospital, The University of Tokyo , 4-6-1, Shirokanedai, Minato-ku, Tokyo 108-8639,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0214-3649","authenticated-orcid":false,"given":"Yingsong","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Public Health, Aichi Medical University School of Medicine , 1-1 Yazakokarimata, Nagakute, Aichi 480-1195,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiharu","family":"Masaki","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Sapporo Medical University , S-1, W-16, Chuo-ku, Sapporo , Hokkaido 060-8543,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"Sasaki","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Sapporo Medical University , S-1, W-16, Chuo-ku, Sapporo , Hokkaido 060-8543,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2848-6586","authenticated-orcid":false,"given":"Hiroshi","family":"Nakase","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Sapporo Medical University , S-1, W-16, Chuo-ku, Sapporo , Hokkaido 060-8543,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Wakai","sequence":"additional","affiliation":[{"name":"Department of Preventive Medicine, Nagoya University, Graduate School of Medicine , 65 Tsurumaicho, Showa-ku, Nagoya , Aichi 466-8550,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuru","family":"Mori","sequence":"additional","affiliation":[{"name":"Hokkaido Chitose College of Rehabilitation , 10, Satomi 2 chome, Chitose , Hokkaido 066-0055,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiko","family":"Tamakoshi","sequence":"additional","affiliation":[{"name":"Department of Public Health, Hokkaido University Faculty of Medicine , Kita 15, Nishi 7, Kita-ku, Sapporo 060-8638,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"For JACC study","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,9,18]]},"reference":[{"key":"2025120323364250300_ref1","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1111\/j.1443-1661.2006.00657.x","article-title":"Insulin-like growth factor-I receptor as a candidate for a novel molecular target in the gastrointestinal cancers","volume":"18","author":"Adachi","year":"2006","journal-title":"Dig Endosc"},{"key":"2025120323364250300_ref2","doi-asserted-by":"publisher","first-page":"5779","DOI":"10.3748\/wjg.v16.i46.5779","article-title":"A candidate targeting molecule of insulin-like growth factor-I receptor for gastrointestinal cancers","volume":"16","author":"Adachi","year":"2010","journal-title":"World J Gastroenterol"},{"key":"2025120323364250300_ref3","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1158\/1078-0432.CCR-14-2056","article-title":"A tale of two receptors: insulin and insulin-like growth factor signaling in cancer","volume":"21","author":"Yee","year":"2015","journal-title":"Clin Cancer Res"},{"key":"2025120323364250300_ref4","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/s41580-025-00826-3","article-title":"Regulation and function of insulin and insulin-like growth factor receptor signalling","volume":"26","author":"Choi","year":"2025","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2025120323364250300_ref5","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1002\/path.1712","article-title":"Insulin-like growth factor ligands, receptors, and binding proteins in cancer","volume":"205","author":"Foulstone","year":"2005","journal-title":"J Pathol"},{"key":"2025120323364250300_ref6","doi-asserted-by":"publisher","first-page":"2877","DOI":"10.1158\/1055-9965.EPI-10-0507","article-title":"Eighteen insulin-like growth factor pathway genes, circulating levels of IGF-I and its binding protein, and risk of prostate and breast cancer","volume":"19","author":"Gu","year":"2010","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2025120323364250300_ref7","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1210\/er.2001-0033","article-title":"Cellular actions of the insulin-like growth factor binding proteins","volume":"23","author":"Firth","year":"2002","journal-title":"Endocr Rev"},{"key":"2025120323364250300_ref8","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s12032-024-02373-x","article-title":"The role of IGFBP-3 in tumor development and progression: enlightenment for diagnosis and treatment","volume":"41","author":"Wang","year":"2024","journal-title":"Med Oncol"},{"key":"2025120323364250300_ref9","first-page":"2007","article-title":"Insulin-like growth factor I overexpression in human pancreatic cancer: evidence for autocrine and paracrine roles","volume":"55","author":"Bergmann","year":"1995","journal-title":"Cancer Res"},{"key":"2025120323364250300_ref10","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1007\/BF02592575","article-title":"Insulin-like growth factor-I, interleukin-1 alpha and beta in pancreatic cancer: role in tumor invasiveness and associated diabetes","volume":"25","author":"Basso","year":"1995","journal-title":"Int J Clin Lab Res"},{"key":"2025120323364250300_ref11","first-page":"7372","article-title":"Insulin-like growth factor-I antagonizes the antiproliferative effects of cyclooxygenase-2 inhibitors on BxPC-3 pancreatic cancer cells","volume":"62","author":"Levitt","year":"2002","journal-title":"Cancer Res"},{"key":"2025120323364250300_ref12","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1126\/science.279.5350.563","article-title":"Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study","volume":"279","author":"Chan","year":"1998","journal-title":"Science."},{"key":"2025120323364250300_ref13","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1016\/S0140-6736(97)10384-1","article-title":"Circulating concentrations of insulin-like growth factor-I and risk of breast cancer","volume":"351","author":"Hankinson","year":"1998","journal-title":"Lancet."},{"key":"2025120323364250300_ref14","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1093\/jnci\/91.7.620","article-title":"Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3","volume":"91","author":"Ma","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"2025120323364250300_ref15","doi-asserted-by":"publisher","first-page":"15125","DOI":"10.1007\/s13277-016-5360-z","article-title":"Insulin-like growth factor-related components and the risk of liver cancer in a nested case-control study","volume":"37","author":"Adachi","year":"2016","journal-title":"Tumour biology: the journal of the International Society for Oncodevelopmental Biology and Medicine"},{"key":"2025120323364250300_ref16","doi-asserted-by":"publisher","first-page":"3488","DOI":"10.3748\/wjg.v23.i19.3488","article-title":"Insulin-like growth factor-1, IGF binding protein-3, and the risk of esophageal cancer in a nested case-control study","volume":"23","author":"Adachi","year":"2017","journal-title":"World J Gastroenterol"},{"key":"2025120323364250300_ref17","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1002\/ijc.20147","article-title":"Serum insulin-like growth factor-I, insulin-like growth factor binding protein-3, and the risk of pancreatic cancer death","volume":"110","author":"Lin","year":"2004","journal-title":"Int J Cancer"},{"key":"2025120323364250300_ref18","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1158\/1055-9965.438.13.3","article-title":"Insulin-like growth factor (IGF)-1, IGF-binding protein-3, and pancreatic cancer in male smokers","volume":"13","author":"Stolzenberg-Solomon","year":"2004","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2025120323364250300_ref19","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/sj.bjc.6603826","article-title":"Circulating insulin-like growth factor axis and the risk of pancreatic cancer in four prospective cohorts","volume":"97","author":"Wolpin","year":"2007","journal-title":"Br J Cancer"},{"key":"2025120323364250300_ref20","doi-asserted-by":"publisher","first-page":"2298","DOI":"10.1158\/1055-9965.EPI-10-0400","article-title":"Serum IGF-I, IGF-II, IGFBP-3, and IGF-I\/IGFBP-3 molar ratio and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian cancer screening trial","volume":"19","author":"Douglas","year":"2010","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2025120323364250300_ref21","doi-asserted-by":"publisher","first-page":"144","DOI":"10.2188\/jea.11.144","article-title":"Japan collaborative cohort study for evaluation of cancer risk sponsored by monbusho (JACC study)","volume":"11","author":"Ohno","year":"2001","journal-title":"J Epidemiol"},{"key":"2025120323364250300_ref22","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.2188\/jea.15.S4","article-title":"Profile of the JACC study","volume":"15","author":"Tamakoshi","year":"2005","journal-title":"J Epidemiol"},{"key":"2025120323364250300_ref23","doi-asserted-by":"publisher","first-page":"227","DOI":"10.2188\/jea.JE20120161","article-title":"Cohort profile of the Japan collaborative cohort study at final follow-up","volume":"23","author":"Tamakoshi","year":"2013","journal-title":"J Epidemiol"},{"key":"2025120323364250300_ref24","first-page":"1","article-title":"Selection of cases and controls for the nested case-control study within the Japan collaborative cohort study: the first-wave","volume":"10","author":"Tamakoshi","year":"2009","journal-title":"Asian Pac J Cancer Prev"},{"key":"2025120323364250300_ref25","doi-asserted-by":"publisher","first-page":"S67","DOI":"10.2188\/jea.15.S67","article-title":"Stability of frozen serum levels of insulin-like growth factor-I, insulin-like growth factor-II, insulin-like growth factor binding protein-3, transforming growth factor beta, soluble Fas, and superoxide dismutase activity for the JACC study","volume":"15","author":"Ito","year":"2005","journal-title":"J Epidemiol"},{"key":"2025120323364250300_ref26","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1111\/jgh.14753","article-title":"Circulating insulin-like growth factor binding protein-3 and risk of gastrointestinal malignant tumors","volume":"34","author":"Adachi","year":"2019","journal-title":"J Gastroenterol Hepatol"},{"key":"2025120323364250300_ref27","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1158\/1940-6207.CAPR-19-0375","article-title":"Insulin-like growth Factor-1, insulin-like growth factor binding Protein-3 and the incidence of malignant neoplasms in a nested case-control study","volume":"13","author":"Adachi","year":"2020","journal-title":"Cancer Prev Res (Phila)"},{"key":"2025120323364250300_ref28","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1093\/jnci\/92.19.1592","article-title":"Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women","volume":"92","author":"Kaaks","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"2025120323364250300_ref29","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1136\/gut.50.5.642","article-title":"Plasma insulin-like growth factor 1, insulin-like growth factor binding protein 3, and risk of colorectal cancer: a prospective study in northern Sweden","volume":"50","author":"Palmqvist","year":"2002","journal-title":"Gut."},{"key":"2025120323364250300_ref30","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1002\/1097-0215(20000801)87:3&lt;373::AID-IJC10&gt;3.0.CO;2-X","article-title":"IGFBP-3 mediates TGF beta 1 proliferative response in colon cancer cells","volume":"87","author":"Kansra","year":"2000","journal-title":"Int J Cancer"},{"key":"2025120323364250300_ref31","doi-asserted-by":"publisher","first-page":"2609","DOI":"10.1002\/1878-0261.12779","article-title":"TGF-beta-induced IGFBP-3 is a key paracrine factor from activated pericytes that promotes colorectal cancer cell migration and invasion","volume":"14","author":"Navarro","year":"2020","journal-title":"Mol Oncol"},{"key":"2025120323364250300_ref32","doi-asserted-by":"publisher","first-page":"286","DOI":"10.3389\/fcell.2020.00286","article-title":"Insulin-like growth factor binding Protein-3 (IGFBP-3): Unraveling the role in mediating IGF-independent effects within the cell","volume":"8","author":"Varma Shrivastav","year":"2020","journal-title":"Frontiers in cell and developmental biology"},{"key":"2025120323364250300_ref33","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1038\/s41417-024-00849-6","article-title":"SEMA7A-mediated juxtacrine stimulation of IGFBP-3 upregulates IL-17RB at pancreatic cancer invasive front","volume":"31","author":"Chen","year":"2024","journal-title":"Cancer Gene Ther"},{"key":"2025120323364250300_ref34","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12752","article-title":"IL-13Ralpha2 uses TMEM219 in chitinase 3-like-1-induced signalling and effector responses","volume":"7","author":"Lee","year":"2016","journal-title":"Nat Commun"},{"key":"2025120323364250300_ref35","doi-asserted-by":"publisher","first-page":"23537","DOI":"10.1002\/jcp.28922","article-title":"The insulin-like growth factor binding protein-3 and its death receptor in pancreatic ductal adenocarcinoma poor prognosis","volume":"234","author":"Gheysarzadeh","year":"2019","journal-title":"J Cell Physiol"},{"key":"2025120323364250300_ref36","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1039\/c3mt20210k","article-title":"The importance of metal ions for the formation and isolation of insulin-like growth factor-binding protein 3-transferrin (IGFBP-3-Tf) complexes, and the analysis of their physiological involvement","volume":"5","author":"Miljus","year":"2013","journal-title":"Metallomics."},{"key":"2025120323364250300_ref37","doi-asserted-by":"publisher","first-page":"S80","DOI":"10.2188\/jea.15.S80","article-title":"Survey for incidence of cancer as a measure of outcome in the JACC study","volume":"15","author":"Mori","year":"2005","journal-title":"J Epidemiol"}],"container-title":["Japanese Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jjco\/article-pdf\/55\/12\/1365\/64315871\/hyaf146.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jjco\/article-pdf\/55\/12\/1365\/64315871\/hyaf146.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T04:37:01Z","timestamp":1764823021000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jjco\/article\/55\/12\/1365\/8257639"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,18]]},"references-count":37,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,9,18]]},"published-print":{"date-parts":[[2025,12,3]]}},"URL":"https:\/\/doi.org\/10.1093\/jjco\/hyaf146","relation":{},"ISSN":["1465-3621"],"issn-type":[{"type":"electronic","value":"1465-3621"}],"subject":[],"published-other":{"date-parts":[[2025,12]]},"published":{"date-parts":[[2025,9,18]]}}}